11.85
Schlusskurs vom Vortag:
$11.67
Offen:
$11.75
24-Stunden-Volumen:
282.71K
Relative Volume:
1.23
Marktkapitalisierung:
$260.74M
Einnahmen:
$52.55M
Nettoeinkommen (Verlust:
$-23.69M
KGV:
-12.60
EPS:
-0.94
Netto-Cashflow:
$-15.29M
1W Leistung:
-0.29%
1M Leistung:
+8.35%
6M Leistung:
+97.26%
1J Leistung:
+362.06%
Exagen Inc Stock (XGN) Company Profile
Firmenname
Exagen Inc
Sektor
Branche
Telefon
(760) 560-1501
Adresse
1261 LIBERTY WAY, VISTA, CA
Vergleichen Sie XGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
XGN
Exagen Inc
|
11.85 | 256.78M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
564.78 | 213.17B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
214.04 | 152.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
720.67 | 50.36B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
144.15 | 41.49B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
213.96 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-11 | Eingeleitet | B. Riley Securities | Buy |
| 2025-07-30 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-23 | Eingeleitet | Craig Hallum | Buy |
| 2022-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-04-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-06-02 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cowen | Outperform |
| 2019-10-14 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Exagen Inc Aktie (XGN) Neueste Nachrichten
What To Expect From Exagen Inc (XGN) Q3 2025 Earnings - GuruFocus
Does Exagen Inc. stock trade at a discount to peers - newser.com
Is Exagen Inc. stock attractive for ETFsEarnings Overview Summary & Daily Profit Maximizing Tips - newser.com
Is Exagen Inc. (E08A) stock good for wealth creationRate Hike & High Accuracy Buy Signal Tips - newser.com
Can Exagen Inc. stock sustain revenue growthJuly 2025 Institutional & Low Risk Entry Point Tips - newser.com
Short interest data insights for Exagen Inc.Inflation Watch & Verified Technical Signals - newser.com
Visual trend scoring systems applied to Exagen Inc.2025 Fundamental Recap & AI Based Buy and Sell Signals - newser.com
Why Exagen Inc. (E08A) stock stays resilient2025 Year in Review & Fast Moving Stock Trade Plans - newser.com
Candlestick signals on Exagen Inc. stock todayTrade Exit Summary & Weekly High Return Forecasts - newser.com
Exagen Inc. stock retracement – recovery analysisTrade Signal Summary & Expert Approved Momentum Trade Ideas - newser.com
Will Exagen Inc. stock split attract more investorsBull Run & Free Expert Approved Momentum Trade Ideas - newser.com
Why Exagen Inc. (E08A) stock stays on buy listsQuarterly Earnings Summary & Short-Term High Return Strategies - newser.com
Is Exagen Inc. stock a defensive play in 2025Weekly Trend Report & Entry Point Strategy Guides - newser.com
What valuation ratios show for Exagen Inc. (E08A) stockGap Down & Risk Adjusted Buy and Sell Alerts - newser.com
Is Exagen Inc. stock a top momentum playJuly 2025 Catalysts & Risk Controlled Stock Pick Alerts - newser.com
Why Exagen Inc. (E08A) stock could be next leader2025 Dividend Review & Free Real-Time Market Sentiment Alerts - newser.com
Can trapped investors hope for a rebound in Exagen Inc.Rate Cut & Technical Pattern Recognition Alerts - newser.com
Will Exagen Inc. stock maintain momentum in 2025Weekly Investment Recap & Stock Timing and Entry Methods - newser.com
How higher bond yields impact Exagen Inc. (E08A) stockJuly 2025 Market Mood & Technical Pattern Recognition Alerts - newser.com
Will Exagen Inc. stock recover faster than peersGap Up & High Yield Stock Recommendations - newser.com
Will Exagen Inc. benefit from macro trendsJuly 2025 Summary & Expert Approved Momentum Trade Ideas - newser.com
How to monitor Exagen Inc. with trend dashboards2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - newser.com
Detecting support and resistance levels for Exagen Inc.Weekly Trade Recap & AI Based Buy/Sell Signal Reports - newser.com
What to do if you’re stuck in Exagen Inc.2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
Why Exagen Inc. stock is considered a top pick2025 Valuation Update & High Conviction Buy Zone Alerts - newser.com
Exagen Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
Will Exagen Inc. stock deliver consistent dividends2025 Market Sentiment & Reliable Price Action Trade Plans - newser.com
Is Exagen Inc. stock poised for growthTrade Analysis Summary & Community Verified Swing Trade Signals - newser.com
Is Exagen Inc. stock attractive for long term wealth buildingGDP Growth & Daily Entry Point Trade Alerts - newser.com
Strategies to average down on Exagen Inc.2025 Macro Impact & Reliable Volume Spike Trade Alerts - newser.com
Exagen Inc. (NASDAQ:XGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Finanzdaten der Exagen Inc-Aktie (XGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):